Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05124353

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05124353
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05124353. Randomized; no masking; primary purpose treatment. Start 2021-04-27 (actual); primary completion 2023-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
Condition
Stroke, Acute, Ischemic
Intervention (Drug)
Cerebrolysin
Lead sponsor
Pomeranian Medical University Szczecin (class: other)

Record details

Record id
cardio:ct-nct05124353
Content hash
a3d24420ac0b87a9937e9ee52124d96ec4c9051ade3758a590ab1f08f19d8dc7